LAPTM5 and metabolic dysfunction-associated steatohepatitis: To confirm the role of hepatic Laptm5 in NASH pathogenesis, we constructed a hepatocyte-specific Laptm5 transgenic (Laptm5-HTG) mice model (Supplementary Fig. 7a and b), with the littermates (NTG) serving as controls.